SAVOY EQUITIES LIMITED NZX Announcement 9 February 2012 Collaboration Agreement AB7 Industries SA The directors of Savoy Equities Limited announced today the company has entered into a collaboration agreement with French company AB7 Industries SA. AB7 Industries was founded in 1972 and produces and distributes biochemical and veterinary products together with water treatment chemicals. The company''s main activity is the manufacture of insecticide and repellent products for pets, horses and cattle. In association with Savoy Equities Limited subsidiary Benefit Healthcare Limited, AB7 will develop Artemisia based active polymers to prevent and help treat the onset of malaria symptoms in humans, and help relieve joint pain in both humans and animals. The AB7 technology permits active ingredients, such as Artemisinin, to be released constantly and consistently over time onto the skin for absorption by the body. More information can be found on the company''s website, www.ab7industries.com The use of a device such as a collar or band to provide relief from the symptoms of malaria or arthritis has the potential to open up a new market segment for the company, especially in the provision of arthritis relief for dogs and malaria treatment in children. Initial activity will focus on the rate of Artemisinin absorption and exposure times required for effective treatment. For further information please contact: Mr. Garrick Wells, Chairman on (04) 528 8854 ENDS End CA:00219335 For:SVY Type:GENERAL Time:2012-02-09 09:23:56
Source: http://www.findata.co.nz/Markets/NZX/55237/GENERAL_SVY_Collaboration_Agreement_AB7_Industries_SA.htm
reno news syracuse shonn greene oklahoma state plane crash syracuse university best buy black friday 2011 ads broncos jets
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.